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Abstract
Background and Purpose—Framingham calculators are typically implemented in one-on-one
settings to determine if a patient has a high risk of developing cardiovascular disease in the next
10 years. Because health care administrative datasets are including more clinical information, we
explored how well administrative data-derived Framingham scores could identify persons who
would develop stroke in the following year.
Methods—Using a nested case-control design, we compared all 313 persons who developed a
first time stroke at 5 VA Medical Centers with a random sample of 25,361 persons who did not
develop a first-time stroke in 2008. We compared Framingham scores and risk using
administrative data available at the end of 2007.
Results—Stroke cases had higher risk profile than controls: older age, higher systolic blood
pressure and total cholesterol, and more likely to have diabetes, cardiovascular disease (CVD), left
ventricular hypertrophy and be on treatment for blood pressure (p<0.05). The mean Framingham
generalized CVD score (18.0 vs. 14.5) as well as the mean Framingham stroke specific score (13.2
vs. 10.2) was higher for stroke cases than controls (both p<0.0001). The c-statistic for the
generalized CVD score was 0.68, 95% Confidence Interval (CI); 0.65–0.70 and for the stroke
score was 0.64, 95% CI; 0.62–0.67.
Conclusions—Persons who develop a stroke in the following year have a worse Framingham
risk profile, as determined by administrative data. Future studies should examine how to improve
the stroke predictive tools and to identify the appropriate populations and uses for applying stroke
risk predictive tools.
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Introduction
Stroke is the third leading cause of death and a major cause of disability in the United States.
1, 2 Because a prior history of stroke is the strongest predictor of a future stroke,
interventions have rightly focused on secondary stroke prevention.3, 4 Yet most of the
795,000 strokes that occur in the United States each year are first-time strokes.2 If a health
care organization can predict risk of first-time stroke using information available in its
administrative database, then population-based strategies can be developed to prevent the
occurrence of a first-time stroke.
Although several stroke risk calculators have been developed for predicting first-time stroke,
they are typically employed in one-on-one physician-patient encounters, not in wide-spread
population screening. Health care administrative datasets are starting to include sufficiently
detailed clinical information to allow calculation of stroke risk. In this study, we investigated
how well stroke calculators based on administrative data could identify persons who would
develop a first-time stroke in the following year.
Methods
Data Source
The Veterans Administration (VA) Desert Pacific Healthcare Network otherwise known as
Veterans Integrated Service Network (VISN) 22 encompasses 5 hospitals and 28
community-based clinics serving 1.2 million veterans residing in southern California and
southern Nevada. VISN-22 provides research support through abstraction of electronic
medical data from individual VA healthcare facilities through a data warehouse which
makes data accessible to investigators for research purposes. The data warehouse has
maintained database that includes separate files for patient demographics, outpatient clinic
and inpatient utilization and diagnostic codes, vital signs, pharmacy utilization, laboratory
data, as well as data on lifestyle habits, such as smoking and exercise since 2002. The
database also contains admissions to non-VA hospitals if the VA reimburses those hospitals
for the care delivered. The VA Greater Los Angeles Institutional Review Board granted
approval for this study.
Study Design
A nested case-control design was used to compare all persons who developed a first-time
stroke during fiscal year (FY) 2008 (October 1, 2007 to September 30, 2008) versus a
random sample of persons who did not develop a first-time stroke in FY2008 (see Figure 1).
Identification of stroke cases and other comorbid conditions used in computing stroke risk
score were done using International Classification of Disease (ICD) codes for these
conditions. Studies that have assessed the validity of information recorded in VA
administrative databases using the ICD codes compared to information abstracted from
original medical record have reported very high levels of agreement.5–7
Stroke cases were identified with the use of ICD codes of hemorrhagic stroke (430.xx,
431.xx) or ischemic stroke (433.x1, 434.x1, 436) assigned as the primary diagnosis upon
hospital discharge. A history of stroke was identified using the above stroke codes or the
code of late effect of stroke (438.x) assigned at inpatient or outpatient settings.
Cases were identified by a new stroke in FY2008. Persons were excluded if they also had a
history of stroke prior to FY2008, as such persons would have suffered a recurrent stroke in
FY2008. Persons were further excluded if they did not have a primary care visit in this VA
network in FY2007 (October 1, 2006 to September 30, 2007) because we wanted to evaluate
Ekundayo et al. Page 2
Stroke. Author manuscript; available in PMC 2012 July 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
the stroke calculator among persons who could have been potentially enrolled in a
hypothetical stroke risk reduction program.
A comparison group was composed of a random sample of all persons who had a primary
care visit within the network in FY2007. Persons were excluded if they were assigned a
history of stroke up to the end of FY2007. Persons were further excluded if they developed a
new stroke during FY2008 because such persons are already included as cases.
Obtaining data for components of the Framingham calculators Stroke risk calculators
The data warehouse contained information for every component of the Framingham
cardiovascular disease (CVD) calculator 8 and the Framingham stroke calculators, 9 but not
for other stroke calculators identified.10–13 Therefore, for both cases and controls, we
obtained all Framingham measurements of age, sex, systolic blood pressure (SBP), blood
pressure treatment, total cholesterol, high density lipoprotein (HDL) cholesterol, and
smoking status during the 12 month period of FY2007. When more than one SBP was
available, the average of the last two outpatient SBP levels was used. When more than one
cholesterol value was available, we used the latest one. Persons were designated to be a
smoker if they had smoked anytime in the past year, in accordance with the VA definition of
smoking.
We then identified whether persons were diagnosed with atrial fibrillation, cardiovascular
disease, left ventricular hypertrophy (LVH), or diabetes using ICD codes assigned from
2002 to the end of FY2007. In the original Framingham study, left ventricular hypertrophy
was diagnosed by electrocardiograms, but because such reports are not included in the data
warehouse, ICD codes for LVH were used instead. For diabetes ascertainment, prescription
of diabetes medications was used in addition to ICD codes, in accordance with the VA
method for identifying patients with diabetes.
In addition, all other available components from other identified stroke calculators were
abstracted from the data warehouse: diastolic blood pressure, body mass index, low density
lipoprotein, alcohol use, cardiomyopathy, creatinine, estimated glomerular filtration rate,
and chronic renal disease.
Analysis
We performed bivariate analyses to compare the stroke cases and the comparison group for
all components of all calculators, including ones not fully used in this study. The
Framingham calculators can be used either by calculating a score based on assigning points
for each component or by calculating an exact 10-year risk based on equations supplied in
the original manuscripts. In both methods missing SBP and cholesterol data were imputed
using the normal values as presented in the 2008 generalized CVD calculator study.8 Mann-
Whitney tests and student t-tests were used to compare Framingham scores and risks, and
95% confidence intervals (CI) were calculated.
The c-statistic was used to quantify the ability of the calculators to discriminate between
persons who did and did not develop a first-time stroke. The c-statistic represents the area
under the receiver operating characteristic curve and varies between 0.50 (no discrimination)
to a maximum of 1.00 (perfect discrimination). In addition, sensitivity, specificity, positive
predictive value (PPV), and negative predictive value (NPV) were calculated using different
cutoffs of Framingham generalized CVD 10-year risk in our sample after weighting our
control group to represent the population from which the random sample was selected. The
Framingham calculators were also used among a subset with age >55 years and again with a
subset with SBP >160 mm Hg, as these subsets concentrate persons at higher risk. Analyses
were performed using SAS, version 9 (SAS Institute Inc., Cary, NC).14
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Two sensitivity analyses were performed. First, all persons with hemorrhagic stroke were
excluded, and then the primary analyses were repeated on persons who develop ischemic
stroke. Second, ICD codes of medical conditions were restricted to only FY2007 instead of
from the inception of the data warehouse, and then the primary analyses were repeated.
Results
In FY 2008, of the 909 persons discharged with a stroke, 403 (44.3%) were recurrent
strokes. Of the remaining 506 persons with first-time stroke in FY2008, 313 persons were
receiving primary care in the network in FY2007. Of these stroke cases, 69 (22%) were
admitted to a non-VA hospital. For the comparison group, there were 221,371 persons who
had a primary care visit in FY2007. Excluding persons who had a history of stroke or who
developed a first-time stroke in FY2008 reduced the number to 218,876 persons. A random
sample of 25, 361 persons (11.6% random sample) served as the comparison group (Table
1).
The stroke cases had a higher risk profile than the comparison group on many components
of the Framingham calculators: older age, predominantly male, higher SBP, higher total
cholesterol, and more likely to have diabetes, CVD, LVH and be on treatment for blood
pressure (all p<0.05, see Table 1). Among non-Framingham components, they were also
more likely to have chronic renal disease and cardiomyopathy. Among stroke cases, 8% did
not have a recorded SBP and 21% did not have a recorded cholesterol value in FY2007;
among controls, 16% did not have a recorded SBP and 27% did not have a recorded
cholesterol value in FY2007 (data not shown).
In Table 2, the mean Framingham generalized CVD score (18.0 vs. 14.5) as well as the
mean Framingham stroke specific score (13.2 vs. 10.2) was higher for stroke cases than
controls (both p<0.0001). The c-statistic for the generalized CVD score was 0.68, 95% CI;
0.65–0.70 and for the stroke score was 0.64, 95% CI; 0.62–0.67. The calculated 10-year risk
using the generalized CVD calculator was also higher among stroke cases than controls
(40% vs. 28%, p<0.0001) and a c-statistic of 0.67, 95% CI; 0.64–0.70.
In a sensitivity analysis, we excluded all 101 persons with hemorrhagic stroke (32%) and
reran analyses to identify the 212 persons with ischemic stroke (Table 3). The c-statistics
were similar to the primary analysis. After restricting data on medical conditions to only
FY2007, we found the same c-statistic of 0.67 (0.62–0.69) using the calculated 10-year risk
using the generalized CVD calculator Test properties of the Framingham generalized CVD
calculator among different thresholds is shown in Table 4. Because the one-year incidence
of first-time stroke was low, the PPV remained low even at the highest Framingham risk
thresholds and among older persons and persons with elevated SBP.
Discussion
The major finding of this study was that it is feasible to generate Framingham scores on
large number of persons using administrative databases. The mean Framingham score was
high for many persons in the control group, but it was still significantly higher for persons
who would develop a first-time stroke in the next year. Therefore, in addition to its current
use for individual patients in one-on-one encounters with a health care provider,
Framingham calculators can also be used for population-wide assessments by healthcare
administrators.
Although the c-statistics reported in our study are comparable to c-statistics of other tools
used in stroke care such as the ABCD2 score and the CHADS2 score,15, 16 our results also
demonstrate a low PPV because the ratio of cases to controls is low. It is important to
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emphasize that in this application, the Framingham calculators are not being used as a
diagnostic tool that guide use of more definitive tests, but instead used as a clinical
prediction tool where no “gold standard” tool for stroke prediction exists. Therefore, a lower
PPV and specificity may be an acceptable tradeoff in order to obtain high sensitivity in
detecting first-time stroke in the near future, so that resources can be targeted to persons at
highest risk.
Differences in the study population, surveillance method, and outcome criteria are three
established reasons why prognostic indexes tested in a different population perform less well
compared to the original derivation study.17 First, our study sample consists of veterans who
use the VA, who are predominantly male and have lower socioeconomic status and health
status compared to the general population.18 Low socioeconomic status was shown to be a
predictor in the QRISK cardiovascular disease risk algorithm.12 Therefore, it is likely that
the Framingham calculator underestimates the risk for stroke in our population because it is
more disadvantaged compared to the general population.18 Second, the original Framingham
cohort studies minimized missing data by making concerted efforts to collect data at all time
points. In contrast, persons in our administrative dataset did not undergo as complete
surveillance for medical conditions and likely possessed undiagnosed conditions that would
have been detected if they were enrolled in a cohort study such as Framingham. By imputing
normal values when they were missing, our calculations underestimate the actual
cardiovascular risk for all persons. Third, we used administrative codes to identify the
outcome variable, development of a first-time stroke. While this approach maximizes the
efficiency and applicability of using such risk prediction tools, it will not be as accurate as a
skilled clinician in identifying persons at risk for stroke, as was done in Framingham.5–7 In
addition, the data warehouse captures some but not all admissions to non-VA hospitals. One
study reported that 76% of dually eligible Medicare and VA patients obtained care for their
initial stroke at non-VA hospitals, 19 as a result not all veterans admitted to non-VA
hospitals may have their data recorded in the data warehouse.
The study has several limitations. We did not have longitudinal data to examine outcomes
beyond one year. In addition, as with all studies conducted in veteran populations, studies
should also be conducted in non-veteran populations before determining whether findings
are generalizable to that population. Identified stroke cases and data obtained for the
components of the Framingham calculator from the VA administrative database used in this
study were not validated by chart abstraction. However, many studies have assessed the
validity of information recorded in VA administrative databases using the ICD codes
compared to information abstracted from original medical record and reported very high
levels of agreement.5–7
Regarding recommendations to future applications of stroke tools using administrative data,
the discriminating abilities of the Framingham calculators was similar using the last year of
data versus using the prior five years of data. The stroke-specific calculator (that includes
atrial fibrillation but not cholesterol) performed similarly to the newer CVD calculator, so
we believe that either calculator could be used. We will be exploring whether the
discrimination of the Framingham calculators can be improved using other clinical data
available in VA databases. However, novel markers such as C - reactive protein have not
been shown to substantially improve upon the already very good discriminating properties
of existing Framingham calculators.20, 21
Conclusions
Persons who develop a first-time stroke do have a significantly higher Framingham risk than
controls based on administrative data available in the year prior to their stroke. While our
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study shows that the proportion of persons who develop a stroke in the following year may
be too low to be easily identified, the c-statistics of administrative data-derived Framingham
scores appear satisfactory enough to attempt predicting a more common outcome, such as
stroke in the following 10 years. As clinical datasets become more available, administrative
data-derived Framingham scores should be further validated to determine their suitability in
studies of population health.
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Figure.
Design of nested-case control study for analyzing how well Framingham calculators can
identify patients who will develop first-time stroke in the following year.
In this study, all cases and controls have had a VA outpatient visit to a primary care provider
in 2007.
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TABLE 1
Characteristics of cases who developed a first-time stroke in 2008 and controls without a first-time stroke by
2008
Developed first- time stroke
(ischemic or hemorrhagic) in
FY2008 N = 313
Did not develop first- time
stroke by FY2008 N = 25,361* p-value
Sociodemographics
 Age, Mean(SD)† 67.2 (11.8) 62.0 (14.9) <0.0001
 Male, %† 97.1 91.6 0.001
 Smoking in the past year, % † 42.2 37.0 0.07
Physiologic measurements in 2007
 Systolic blood pressure, mean (SD), mm Hg †, § 138.1 (20.5) 129.8 (16.2) <0.0001
 Diastolic blood pressure, mean(SD), mm Hg § 13.2 10.9 <0.0001
 Body mass index 29.0 (5.9) 29.3 (6.5) 0.38
 Prescription of medication for BP, % † 76.7 61.0 <0.0001
Laboratory values in 2007
 Total cholesterol, mean (SD) mg/dL † 181.7 (48.9) 174.4 (42.4) 0.02
 High-density lipoprotein, mean (SD), mg/dL † 41.4 (14.0) 42.3 (13.4) 0.21
 Low-density lipoprotein cholesterol, mean (SD), mg/dL 111.6 (41.3) 103.9 (34.1) 0.005
 Creatinine, mean (SD) 7.6 (31.7) 6.3 (29.8) 0.45
 Glomerular filtration rate, mean (SD) 69.6 (26.7) 76.3 (24.6) <0.0001
Diagnosis codes from 2002–2007
 Alcoholism, % 10.5 12.5 0.30
 Atrial fibrillation, % † 10.5 8.7 0.25
 Cardiomyopathy, % 4.8 2.5 0.01
 Cardiovascular disease, % † 34.5 25.4 0.0002
 Chronic renal disease, % 16.6 8.4 <0.0001
 Diabetes, % †, || 42.2 30.8 <0.0001
 Left ventricular hypertrophy, % † 15.0 9.3 0.001
BP indicates, blood pressure; SD, standard deviation
*
Weighted to represent 218,876 persons
†
Component of the Framingham generalized cardiovascular disease or stroke calculator
§
Average of the last two outpatient BP levels
||
Diagnosis codes for diabetes or the use of diabetic medications
Stroke. Author manuscript; available in PMC 2012 July 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Ekundayo et al. Page 10
TABLE 2
Performance of Framingham calculators to identify first-time stroke
Ischemic or hemorrhagic
stroke in FY2008 N = 313
No Stroke FY2008 N =
25,361*
c-statistic (95% confidence
interval)
Framingham generalized CVD calculator:
 Score, mean (SD) 18.0 (4.2)† 14.5 (5.9) 0.68 (0.65–0.70)
 Estimated 10-year risk based on score§ >30% 21.6% -
 Calculated 10-year risk CVD, % 40.1%† 28.0% 0.67 (0.64–0.70)
Framingham stroke specific score, mean(SD)
 Score, mean (SD) 13.2 (6.1)† 10.2 (6.2) 0.64 (0.62–0.67)
 Estimated 10-year stroke risk based on
score§,||
15.0% 10.0% -
CVD indicates, cardiovascular disease; SD, standard deviation
*
Weighted to represent 218,876 persons
†
p<0.0001
§
Based on information provided in the Framingham study8,9
||
Insufficient information to calculate the 10-year stroke risk9
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TABLE 3
Performance of Framingham calculators to identify first-time ischemic stroke
Ischemic stroke in
FY2008 N = 212
No Stroke FY2008 N =
25,361*
c-statistic (95% confidence
interval)
Framingham generalized CVD calculator:
 Score, mean (SD) 18.3 (4.2)† 14.5 (5.9) 0.69 (0.66–0.73)
 Estimated 10-year risk based on score§ >30% 21.6% -
 Calculated 10-year risk CVD, % 41.4%† 28.0% 0.69 (0.65–0.72)
Framingham stroke specific score, mean(SD)
 Score, mean (SD) 13.6 (6.1)† 10.2 (6.2) 0.65 (0.63–0.69)
 Estimated 10-year stroke risk based on score§,
||
17.0% 10.0% -
CVD indicates, cardiovascular disease; SD, standard deviation
*
Weighted to represent 218,876 persons
†
p<0.0001
§
Based on information provided in the Framingham study8,9
||
Insufficient information to calculate the 10-year stroke risk9
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